Press Releases

Oct 07, 2019
Axcella Provides Progress Updates for Liver Program Candidates AXA1125 and AXA1957
Oct 01, 2019
Axcella Announces Presentations at the American Association for the Study of Liver Disease (AASLD) The Liver Meeting
Aug 23, 2019
Axcella Health Inc. Announces Appointment of Catherine A. Sohn, Pharm. D. to its Board of Directors
Aug 12, 2019
Axcella Health Reports Second Quarter 2019 Financial Results and Provides Company Update
Aug 07, 2019
Axcella to Present at the Wedbush PacGrow Healthcare Conference
Jul 31, 2019
Axcella Announces Publication of Data Describing Attenuation of Muscle Atrophy with AXA2678 in Short-Term Muscle Disuse Study
Jun 20, 2019
Axcella Health Reports First Quarter 2019 Financial Results and Provides Company Update
May 13, 2019
Axcella Health Announces Closing of Initial Public Offering
May 08, 2019
Axcella Health Announces Pricing of Initial Public Offering
Apr 11, 2019
Axcella Presents Late-Breaker Data Demonstrating Lead AXA™ Candidate AXA1665 Impacted Markers Related to Liver Health
Displaying 1 - 10 of 16